A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated with Huntington's Disease

Administered By

Awarded By

Contributors

Start/End

  • October 3, 2019 - December 31, 2021